Research News and Research

RSS

Viral Genetics: Company update

Our mission is to bring new drug compounds to the marketplace. And we've never been in a stronger position to deliver on that promise. We've built the solid foundation needed to take drug therapies from the laboratory to the marketplace. After years in development, we believe several of our most promising compounds are moving closer to clinical trials.

12 Feb 2010

First Edition: February 12, 2010

Today's headlines highlight the continuing flap over Anthem Blue Cross' planned rate hike as well as GOP and Democratic responses to President Obama's proposed health summit.

12 Feb 2010

HIV transmission among male partners: CFAR scientists discover origin of strains

A team of scientists, led by a virologist from the University of California, San Diego's Center for AID Research (CFAR), has discovered the origin of strains of human immunodeficiency virus (HIV) among men who have sex with men. The study, which may be important in developing prevention strategies for HIV, will appear in Science Translational Medicine on February 10, 2010.

12 Feb 2010

ISMPP announces opening of registration for 6th annual meeting on medical publications

The International Society for Medical Publication Professionals (ISMPP) is pleased to announce the opening of registration for its 6th annual meeting, "Delivering Value and Driving Advocacy in Medical Publications." The meeting will run from April 19 to 21, 2010, in Arlington, VA, at the Crystal Gateway Marriott.

12 Feb 2010

Gold nanoparticles for cancer treatment

World Gold Council (WGC) has today published 'Gold for Good: Gold and nanotechnology in the age of innovation', a research paper detailing new scientific and technological innovations using gold. The report, which was produced in conjunction with Cientifica Ltd, the world's leading source of global business and investor intelligence about nanotechnologies, demonstrates how gold nanoparticles offer the potential to overcome many of the serious issues facing mankind over the coming decades.

12 Feb 2010

New project to unravel secret lives of cancer cells may help produce new cancer therapies

A team of scientists from Princeton University and The Cancer Institute of New Jersey has embarked on a major new project to unravel the secret lives of cancer cells that go dormant and self-cannibalize to survive periods of stress. The work may help produce new cancer therapies to stem changes that render cancer cells dangerous and resistant to treatment.

12 Feb 2010

World leaders need to alter their notions on sustainable agriculture to prevent starvation catastrophe

Yields from some of the most important crops begin to decline sharply when average temperatures exceed about 30 degrees Celsius, or 86 Fahrenheit. Projections are that by the end of this century much of the tropics and subtropics will regularly see growing season temperatures above that level, hotter than the hottest summers now on record.

12 Feb 2010

Treating bacteria with insufficient levels of antibiotics leads to multidrug resistance in 'superbugs'

For years, doctors have warned patients to finish their antibiotic prescriptions or risk a renewed infection by a "superbug" that can mount a more powerful defense against the same drug. But a new study by Boston University biomedical engineers indicates that treating bacteria with levels of antibiotics insufficient to kill them produces germs that are cross-resistant to a wide range of antibiotics.

12 Feb 2010

Data demonstrates the effectiveness of NeuroAiD on neuronal and brain injuries

The January issue of "Neuropharmacology", publishes the article entitled "Neuroprotective and Neuroproliferative Activities of NeuroAiD", reporting pharmacological data establishing NeuroAiD (MLC 601) protective effects on neuronal and brain injuries as well as its effectiveness in neurological functions recovery.

12 Feb 2010

Anti-PC antibody linked to reduced risk of arteriosclerosis

The chances of suffering a stroke are linked to the presence of a certain type of antibody in the immune system, a new study from Karolinska Institutet shows. The researchers hope to be able to develop a vaccine that can mobilise the body's own defence against arteriosclerosis and stroke.

12 Feb 2010

Peregrine Pharmaceuticals' Cotara specifically targets solid tumors and anti-tumor activity

Peregrine Pharmaceuticals, Inc. (PPHM) today reported publication of data in the online edition of the journal Current Cancer Therapy Reviews that supports the clinical potential of the company's novel brain cancer agent Cotara® for the treatment of patients with glioblastoma multiforme (GBM), the deadliest form of brain cancer. Cotara specifically targets cells at the center of brain tumors, so its radioactive payload is able to kill cancer cells while leaving healthy tissue largely unaffected. Cotara is currently being tested in a Phase II clinical trial in recurrent GBM patients.

12 Feb 2010

Better and standardized animal models needed for musculoskeletal regenerative medicine

Clinical testing and development of novel therapies based on advances in tissue engineering and regenerative medicine that will one day enable the repair and replacement of diseased or damaged human muscle, bone, tendons, and ligaments depends on the availability of good animal models.

12 Feb 2010

Sun Knowledge to attend Annual Drug Benefit Conference in Phoenix

Sun Knowledge, Ltd., a leading Healthcare Insurance provider of Knowledge Process Outsourcing (KPO) services, will attend the Pharmacy Benefit Management Institute’s Annual Drug Benefit Conference in Phoenix, Az., from February 17-19.

12 Feb 2010

Also in Global Health News: China's health care system; Breastfeeding practices in Pakistan; HIV transmission in MSM; Abu Dhabi joins malaria fight

The Los Angeles Times examines China's transition to "Western-style privatized medicine" through the government's "$124-billion overhaul, chiefly to improve service in rural areas." The article details the efforts of a woman from Inner Mongolia to get care in Beijing for her ailing father and looks at climbing health care costs and the growing "black market for medical care" (Pierson, 2/11).

12 Feb 2010

Article features pelvic health problems, risk factors and treatment options for women

Pelvic health concerns in women are common -- yet how the issues impact sexuality and childbearing is not often discussed, according to Mayo Clinic Women's HealthSource.

12 Feb 2010

United Airlines to deliver teddy bears to kids undergoing cancer treatment across the country

Starting today, United Airlines employees will begin delivering thousands of teddy bears to kids undergoing cancer treatment at hospitals across the country through a partnership with the American Cancer Society® that raised almost 27 million Mileage Plus miles.

12 Feb 2010

Antibodies also contribute to severe dengue virus-induced disease, confirms La Jolla Institute for Allergy & Immunology

A leading immunology research institute has validated the long-held and controversial hypothesis that antibodies - usually the "good guys" in the body's fight against viruses - instead contribute to severe dengue virus-induced disease, the La Jolla Institute for Allergy & Immunology announced today. The finding has major implications for the development of a first-ever vaccine against dengue virus, a growing public health threat which annually infects 50 to 100 million people worldwide, causing a half million cases of the severest form.

12 Feb 2010

SSA to add early-onset Alzheimer's disease to its Compassionate Allowances Initiative

In its effort to improve and expedite the disability determination process, the Social Security Administration has announced that it will add early-onset Alzheimer's disease to its Compassionate Allowances Initiative. The initiative identifies debilitating diseases and medical conditions that meet the SSA's disability standards for Social Security Disability Income (SSDI) or Supplemental Security Income (SSI).

12 Feb 2010

NeoStem prices public offering of 5M common stock shares at $1.35 per share

NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced today that it priced a public offering of 5,000,000 shares of its common stock at $1.35 per share. Net proceeds from the offering, after underwriting discounts and commissions and expenses, will be approximately $5,697,500. NeoStem has granted the underwriters an option to purchase up to an additional 750,000 shares to cover over-allotments, if any.

12 Feb 2010

Parents often recognize signs of asthma in their children but delay home treatment: Report

Parents of young children with asthma often recognize signs that their child is about to have an asthma attack but delay home treatment until the attack occurs, researchers at Washington University School of Medicine in St. Louis report.

12 Feb 2010

Research News and Research

Viral Genetics: Company update

First Edition: February 12, 2010

HIV transmission among male partners: CFAR scientists discover origin of strains

ISMPP announces opening of registration for 6th annual meeting on medical publications

Gold nanoparticles for cancer treatment

New project to unravel secret lives of cancer cells may help produce new cancer therapies

World leaders need to alter their notions on sustainable agriculture to prevent starvation catastrophe

Treating bacteria with insufficient levels of antibiotics leads to multidrug resistance in 'superbugs'

Data demonstrates the effectiveness of NeuroAiD on neuronal and brain injuries

Anti-PC antibody linked to reduced risk of arteriosclerosis

Peregrine Pharmaceuticals' Cotara specifically targets solid tumors and anti-tumor activity

Better and standardized animal models needed for musculoskeletal regenerative medicine

Sun Knowledge to attend Annual Drug Benefit Conference in Phoenix

Also in Global Health News: China's health care system; Breastfeeding practices in Pakistan; HIV transmission in MSM; Abu Dhabi joins malaria fight

Article features pelvic health problems, risk factors and treatment options for women

United Airlines to deliver teddy bears to kids undergoing cancer treatment across the country

Antibodies also contribute to severe dengue virus-induced disease, confirms La Jolla Institute for Allergy & Immunology

SSA to add early-onset Alzheimer's disease to its Compassionate Allowances Initiative

NeoStem prices public offering of 5M common stock shares at $1.35 per share

Parents often recognize signs of asthma in their children but delay home treatment: Report

Spectroscopy Applications in the Environment eBook eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring